Beijing Biostar Pharmaceuticals announces annual general meeting

• Beijing Biostar Pharmaceuticals will hold its annual general meeting in Beijing on June 26, 2026.
• Shareholders will vote on the 2025 audited financial statements, the annual report, the profit distribution proposal, and ratification of connected transactions.
• The meeting will also consider a 2026 directors’ pay package, appoint Dr. Zhu Xiaodong as an independent non-executive director, and re-appoint WUYIGE Certified Public Accountants LLP as auditor.
• Special resolutions include mandates to issue up to 20% of shares and to repurchase up to 10% of H shares.
• Other items include scrapping the supervisory committee, amending the articles of association, and adopting a share option scheme with related authorizations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beijing Biostar Pharmaceuticals Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260528-12175713), on May 28, 2026, and is solely responsible for the information contained therein.